22 May 2013
Keywords: par, licenses, rights, hana, zensana, up, 50m
Article | 06 August 2007
Hana Biosciences has entered into an exclusive licensing agreement with fellow USA-based Par Pharmaceuticals for the development and sale
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 August 2007
21 May 2013
© 2013 thepharmaletter.com